ABSI
Price
$3.10
Change
+$0.22 (+7.64%)
Updated
Jul 18, 03:46 PM (EDT)
Capitalization
367.37M
32 days until earnings call
QURE
Price
$15.01
Change
-$0.19 (-1.25%)
Updated
Jul 18, 04:59 PM (EDT)
Capitalization
832.18M
13 days until earnings call
Interact to see
Advertisement

ABSI vs QURE

Header iconABSI vs QURE Comparison
Open Charts ABSI vs QUREBanner chart's image
Absci
Price$3.10
Change+$0.22 (+7.64%)
Volume$477
Capitalization367.37M
uniQure
Price$15.01
Change-$0.19 (-1.25%)
Volume$24.92K
Capitalization832.18M
ABSI vs QURE Comparison Chart in %
Loading...
ABSI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
QURE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ABSI vs. QURE commentary
Jul 18, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ABSI is a Hold and QURE is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 18, 2025
Stock price -- (ABSI: $2.88 vs. QURE: $15.20)
Brand notoriety: ABSI and QURE are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ABSI: 266% vs. QURE: 176%
Market capitalization -- ABSI: $367.37M vs. QURE: $832.18M
ABSI [@Biotechnology] is valued at $367.37M. QURE’s [@Biotechnology] market capitalization is $832.18M. The market cap for tickers in the [@Biotechnology] industry ranges from $299.62B to $0. The average market capitalization across the [@Biotechnology] industry is $2.46B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ABSI’s FA Score shows that 0 FA rating(s) are green whileQURE’s FA Score has 0 green FA rating(s).

  • ABSI’s FA Score: 0 green, 5 red.
  • QURE’s FA Score: 0 green, 5 red.
According to our system of comparison, both ABSI and QURE are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ABSI’s TA Score shows that 5 TA indicator(s) are bullish while QURE’s TA Score has 6 bullish TA indicator(s).

  • ABSI’s TA Score: 5 bullish, 4 bearish.
  • QURE’s TA Score: 6 bullish, 3 bearish.
According to our system of comparison, QURE is a better buy in the short-term than ABSI.

Price Growth

ABSI (@Biotechnology) experienced а +5.49% price change this week, while QURE (@Biotechnology) price change was +2.15% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.74%. For the same industry, the average monthly price growth was +13.30%, and the average quarterly price growth was +34.86%.

Reported Earning Dates

ABSI is expected to report earnings on Nov 05, 2025.

QURE is expected to report earnings on Oct 29, 2025.

Industries' Descriptions

@Biotechnology (+2.74% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
QURE($832M) has a higher market cap than ABSI($367M). ABSI YTD gains are higher at: 9.924 vs. QURE (-13.930). ABSI has higher annual earnings (EBITDA): -93.91M vs. QURE (-138.01M). QURE has more cash in the bank: 409M vs. ABSI (134M). ABSI has less debt than QURE: ABSI (8.92M) vs QURE (66.2M). QURE has higher revenues than ABSI: QURE (20.2M) vs ABSI (4.82M).
ABSIQUREABSI / QURE
Capitalization367M832M44%
EBITDA-93.91M-138.01M68%
Gain YTD9.924-13.930-71%
P/E RatioN/AN/A-
Revenue4.82M20.2M24%
Total Cash134M409M33%
Total Debt8.92M66.2M13%
FUNDAMENTALS RATINGS
QURE: Fundamental Ratings
QURE
OUTLOOK RATING
1..100
8
VALUATION
overvalued / fair valued / undervalued
1..100
79
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
49
P/E GROWTH RATING
1..100
91
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ABSIQURE
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
84%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
79%
MACD
ODDS (%)
Bullish Trend 2 days ago
89%
Bullish Trend 2 days ago
84%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
88%
Bullish Trend 2 days ago
74%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
85%
Bearish Trend 2 days ago
87%
Advances
ODDS (%)
Bullish Trend 2 days ago
89%
Bullish Trend 2 days ago
74%
Declines
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 22 days ago
86%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
88%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
76%
View a ticker or compare two or three
Interact to see
Advertisement
ABSI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
QURE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
NMIEX13.07N/A
N/A
Northern Active M International Equity
LZSMX10.13N/A
N/A
Lazard International Small Cap Eq Open
OEGCX19.60N/A
N/A
Invesco Discovery Mid Cap Growth C
TNVAX17.76N/A
N/A
1290 GAMCO Small/Mid Cap Value A
IOAPX29.48N/A
N/A
Invesco Main Street All Cap R6